Pfizer Inc
NYSE: PFE
$28.46
-$0.40 (-1.4%)
Closing Price on October 29, 2024
PFE Articles
Merrill Lynch points to five companies that, in their words, should be key players in the young but growing biosimilar market.
Published:
Last Updated:
When Pfizer released its third-quarter earnings report before the markets opened on Tuesday, the results and guidance lived up to what analysts expected but weren't enough to placate investors.
Published:
Pfizer is scheduled to release its third-quarter financial results before the markets open on Tuesday.
Published:
The busiest earnings week of the season has come and gone, but there are still plenty more big names stepping into the spotlight this week.
Published:
24/7 Wall St. has collected a few pharma and biotech catalysts that are coming up on the calendar in November and December.
Published:
The October 13 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks increased.
Published:
Last Updated:
Among the most shorted stocks traded on the New York Stock Exchange, two struggling retailers saw notable growth in their short interest in the latest reporting period.
Published:
Last Updated:
Here are 13 featured spin-offs already underway and potential spin-offs that could be seen in 2017 and into 2018 that could radically change how Wall Street and Main Street evaluate companies ahead.
Published:
Last Updated:
The September 29 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks decreased.
Published:
Last Updated:
The September 15 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks increased.
Published:
Last Updated:
If there is one cure or one treatment that could be the proverbial Holy Grail for a pharmaceutical or biotech company, it would be in a successful treatment of Alzheimer's disease.
Published:
Last Updated:
Apple and 3M weighed on the DJIA Wednesday while McDonald's and Pfizer gave the index a boost.
Published:
Last Updated:
United Technologies, Pfizer, Merck, and Boeing were the stalwarts among the DJIA index stocks on Thursday.
Published:
Last Updated:
Although the markets were mixed on Thursday, major drug manufacturers proved to be one of the more positive segments on the day.
Published:
Last Updated:
The August 31 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks increased.
Published:
Last Updated: